What Theseus Pharmaceuticals, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Dukes Iain D. | Director | Feb 14 | Tender Offer · U | −388,324 | — | — | 0 |
| Gordon Carl L | Director | Feb 14 | Tender Offer · U | −650,600 | — | — | 0 |
| Gordon Carl L | Director | Feb 14 | Tender Offer · U | −17,063,000 | — | — | 0 |
| Orbimed Advisors Llc | Director | Feb 14 | Tender Offer · U | −650,600 | — | — | 0 |
| Orbimed Advisors Llc | Director | Feb 14 | Tender Offer · U | −17,063,000 | — | — | 0 |
| Dahms Bradford D. | President and CFO | Feb 14 | Tender Offer · U | −8,150 | — | — | 0 |
| Hayden Donald J Jr | Director | Feb 14 | Tender Offer · U | −10,000 | — | — | 0 |
| Shakespeare William | See Remarks | Nov 06 | Exercise / conversion · M | +251,084 | $0.32 | +$80.3K | 639,408 |
| Foresite Capital Management V, Llc | 10% owner | Jul 17 | Open-market buy · P | +176,550 | $2.97 | +$524K | 1,385,825 |
| Foresite Capital Management V, Llc | 10% owner | Jul 17 | Open-market buy · P | +523,450 | $2.97 | +$1.55M | 4,108,796 |
| Gordon Carl L | Director | Jul 17 | Open-market buy · P | +151,450 | $3.05 | +$462K | 650,600 |
| Gordon Carl L | Director | Jul 17 | Open-market buy · P | +328,482 | $3.05 | +$1M | 17,063,000 |
| Orbimed Advisors Llc | Director | Jul 17 | Open-market buy · P | +151,450 | $3.05 | +$462K | 650,600 |
| Orbimed Advisors Llc | Director | Jul 17 | Open-market buy · P | +328,482 | $3.05 | +$1M | 17,063,000 |
| Hayden Donald J Jr | Director | Dec 30 | Open-market buy · P | +9,900 | $5.00 | +$49.5K | 10,000 |
| Foresite Capital Management V, Llc | 10% owner | Dec 29 | Open-market buy · P | +250,000 | $5.00 | +$1.25M | 1,209,275 |
| Foresite Capital Management V, Llc | 10% owner | Dec 29 | Open-market buy · P | +250,000 | $5.00 | +$1.25M | 3,585,346 |
| Hayden Donald J Jr | Director | Dec 29 | Open-market buy · P | +100 | $5.00 | +$500 | 100 |
| Dahms Bradford D. | Chief Financial Officer | Nov 30 | Open-market buy · P | +1,502 | $6.66 | +$10K | 6,142 |
| Clackson Timothy P | President and CEO | Nov 11 | Open-market buy · P | +2,500 | $6.80 | +$17K | 351,030 |
Loading...